Top 5 Key Takeaways from ECCMID 2019

Article

Here are the top takeaways from the European Congress of Clinical Microbiology and Infectious Disease 2019 meeting.

ECCMID 2019 was held April 13-16, 2018, in Amsterdam, the Netherlands. The conference featured results of new studies on a variety of infectious disease and microbiology topics as well as advancements being made across the fields. Here are 5 key takeaways from the meeting.

Read more about these stories:

  • FURI Study Case: Ibrexafungerp Successfully Treats Esophageal Candidiasis
  • CAMERA2: Combination Therapy for MRSA Bacteremia Effective but Linked to Higher Mortality, AKI Rates
  • Most Patients With UTI Symptoms Receive Antibiotics, Yet Lack Evidence of Infection
  • Jose Arribas, MD, on the Challenges That Come With Long-Acting Injectables
  • ASPECT-NP: Ceftolozane/Tazobactam Efficacious for Ventilated Nosocomial Pneumonia

Newsletter

Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.

Recent Videos
© 2025 MJH Life Sciences

All rights reserved.